16729-247 : Mitomycin 20 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution
| NDC: | 16729-247 |
| Labeler: | Accord Healthcare Inc |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Mitomycin |
| Dosage Form: | Intravenous Injection, Powder, Lyophilized, for Solution |
| Application #: | ANDA064144 |
| Rev. Date: |
NDC Package Codes:
- 16729-247-11: 1 VIAL IN 1 CARTON (16729‑247‑11) > 10 ML IN 1 VIAL
Active Ingredients:
- Mitomycin
Dosage Strength:
- 20 mg/10mL
Pharmaceutical Classes:
- Alkylating Activity [MoA]
- Alkylating Drug [EPC]
Related Products:
Based on records with the same trade name.- 16729-108 Mitomycin 20 mg/40ml Intravenous Injection, Powder, Lyophilized, for Solution by Accord Healthcare Inc
- 16729-115 Mitomycin 5 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Accord Healthcare Inc
- 16729-116 Mitomycin 40 mg/80ml Intravenous Injection, Powder, Lyophilized, for Solution by Accord Healthcare Inc
- 16729-246 Mitomycin 5 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Accord Healthcare Inc
- 16729-248 Mitomycin 40 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Accord Healthcare Inc
- 0143-9279 Mitomycin 20 mg/40ml Intravenous Injection, Powder, Lyophilized, for Solution by West-ward Pharmaceuticals Corp
- 0143-9280 Mitomycin 40 mg/80ml Intravenous Injection, Powder, Lyophilized, for Solution by West-ward Pharmaceuticals Corp
- 67457-518 Mitomycin 5 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Mylan Institutional LLC
- 67457-519 Mitomycin 20 mg/40ml Intravenous Injection, Powder, Lyophilized, for Solution by Mylan Institutional LLC
- 67457-520 Mitomycin 40 mg/80ml Intravenous Injection, Powder, Lyophilized, for Solution by Mylan Institutional LLC
- 68001-389 Mitomycin 5 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
- 68001-390 Mitomycin 20 mg/40ml Intravenous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
- 68001-391 Mitomycin 40 mg/80ml Intravenous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 16729-246Next: 16729-248 >
Related Discussions:
bcg vs. mitomycin
treatment with mitomycin on bladder cancer was not tolerated. physician wishes to treat now with BCG. Comments?...
treatment with mitomycin on bladder cancer was not tolerated. physician wishes to treat now with BCG. Comments?...
material safety data sheet-mitomycin
mitomycin ## Here's the site for that product with such information for you: Material Safety Data Mitomycin Click He... 2 replies
mitomycin ## Here's the site for that product with such information for you: Material Safety Data Mitomycin Click He... 2 replies
Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.